I/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Our Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyselfWe had aphase 2btrial with100%efficacyI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BI/ONTAKis our leadassetI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013We haveenough cashto go wellinto 2023Mino-Lokis our leadassetWe intendto submita BLA in2H 2022We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateHemorrhoidsis a $2BmarketMino-WrapWe expect tofinish theMino-Loktrial this yearThere are noFDAapproveddrugs to treathemorrhoidsI/ONTAK'spotentialmarket is>$300mInsidersinvested$26.5mThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Our Halo-Lido trial willhave finalpatient byend of 2022I'm ashareholdermyselfWe had aphase 2btrial with100%efficacyI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.Mino-Lokpotentialmarket>$1BI/ONTAKis our leadassetI won't diluteshareholdersMyron Holubiakand I founded aprivatecompany in2013We haveenough cashto go wellinto 2023Mino-Lokis our leadassetWe intendto submita BLA in2H 2022We willhaveexclusivityOnly biotechwith 2 Myron'son theleadershipteamI/ONTAKwas thebest deal Iever madeNot manycompaniesthis size with2 late stageassetsWe will openupinternationalsites forMino-Lok trialAn actualiMSCupdateHemorrhoidsis a $2BmarketMino-WrapWe expect tofinish theMino-Loktrial this yearThere are noFDAapproveddrugs to treathemorrhoids

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. I/ONTAK's potential market is >$300m
  2. Insiders invested $26.5m
  3. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  4. Our Halo-Lido trial will have final patient by end of 2022
  5. I'm a shareholder myself
  6. We had a phase 2b trial with 100% efficacy
  7. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  8. Mino-Lok potential market >$1B
  9. I/ONTAK is our lead asset
  10. I won't dilute shareholders
  11. Myron Holubiak and I founded a private company in 2013
  12. We have enough cash to go well into 2023
  13. Mino-Lok is our lead asset
  14. We intend to submit a BLA in 2H 2022
  15. We will have exclusivity
  16. Only biotech with 2 Myron's on the leadership team
  17. I/ONTAK was the best deal I ever made
  18. Not many companies this size with 2 late stage assets
  19. We will open up international sites for Mino-Lok trial
  20. An actual iMSC update
  21. Hemorrhoids is a $2B market
  22. Mino-Wrap
  23. We expect to finish the Mino-Lok trial this year
  24. There are no FDA approved drugs to treat hemorrhoids